EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alanyl-Glutamine Dipeptide Mitigates E. coli-Induced Pathogenesis in Hy-Line Brown Hens: Mechanistic Insights into Microbiome Modulation, Antioxidant Response, and Intestinal Integrity

Usman Nazir, Zhi Yang iD, Muhammad Hammad Zafar iD, Xiaoli Wan iD, Haiming Yang

International Journal of Molecular Sciences · 02.08.2026 · 27 (15) · 6936

DOI: 10.3390/ijms27156936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2026. Verfasst von Usman Nazir und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China. Hauptthemen laut MEDLINE: Dipeptides, Escherichia coli, Escherichia coli Infections, Antioxidants. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jurong Agricultural Technology Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli (E. coli) infection in poultry triggers severe diarrhea and intestinal damage, ultimately disrupting gut function. Alanyl-glutamine (Aln-Gln) dipeptide not only exhibits potent gut-repairing efficacy but also restores barrier integrity and counters E. coli pathology through mucosal healing and immune modulation. In this study, the effects of Aln-Gln on microbiome modulation and intestinal integrity in growing hens challenged with E. coli were evaluated. The 250 healthy, Hy-line brown pullets (42 days old) were randomly divided into 5 experimental groups, each having five replicates of 10 chicks. Five dietary groups include a basal diet without added Aln-Gln and no E. coli challenge (NC), a basal diet without added Aln-Gln and orally administered 2.0 × 104 CFU/mL E. coli suspension (C), a basal diet added 0.1% Aln-Gln and orally administered 2.0 × 104 CFU/mL E. coli suspension (G1), a basal diet added 0.2% Aln-Gln and orally administered 2.0 × 104 CFU/mL E. coli suspension (G2) and a basal diet added 0.3% Aln-Gln and orally administered 2.0 × 104 CFU/mL E. coli suspension (G3). The results showed that dietary supplementation with 0.2% or 0.3% Aln-Gln effectively mitigated the adverse effects of an E. coli challenge, restoring body weight and feed intake to levels comparable to non-challenged controls. Aln-Gln supplementation (0.2–0.3%) reduced diarrhea severity, restored ileal morphology (villus height, crypt depth), improved antioxidant enzyme activity (GSH-Px, SOD), and reduced oxidative markers (MDA) (p < 0.05). Aln-Gln decreased pro-inflammatory (IL-1β, IL-6, NO) and apoptotic (BAX) responses (p < 0.05) and enhanced barrier integrity. It rebalanced gut microbiota by suppressing pathogenic Clostridium (75% in C vs. 29.9% in G3) and increasing beneficial Lactobacillus in G2/G3 compared with C. These findings demonstrate Aln-Gln as a beneficial dietary additive that restores growth performance and gut integrity; reduces diarrhea severity, inflammation, and apoptosis; and improves antioxidant status as it rebalances gut microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipeptidesEscherichia coliEscherichia coli InfectionsAntioxidantsGastrointestinal MicrobiomePoultry DiseasesAnimalsChickensFemaleIntestinesIntestinal MucosaDietary SupplementsOxidative StressAnimal FeedIntestinal Barrier Function

Stichwörter der Autor:innen

E. coliantioxidantchallengediarrheagrowing hensgutmicrobiome

Substanzen

DipeptidesalanylglutamineAntioxidants

Autor:innen und Institutionen

  • College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China.
  • College of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
  • Joint International Research Laboratory of Agriculture and Agri-Product Safety of Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.

ORCID-Profile: Zhi Yang, Muhammad Hammad Zafar, Xiaoli Wan

Förderung

  • Jurong Agricultural Technology Innovation Fund

Zitieren

APA

Nazir, U., Yang, Z., Zafar, M. H., Wan, X., & Yang, H. (2026). Alanyl-Glutamine Dipeptide Mitigates E. coli-Induced Pathogenesis in Hy-Line Brown Hens: Mechanistic Insights into Microbiome Modulation, Antioxidant Response, and Intestinal Integrity. International Journal of Molecular Sciences, 27(15), 6936. https://doi.org/10.3390/ijms27156936

Vancouver

Nazir U, Yang Z, Zafar MH, Wan X, Yang H. Alanyl-Glutamine Dipeptide Mitigates E. coli-Induced Pathogenesis in Hy-Line Brown Hens: Mechanistic Insights into Microbiome Modulation, Antioxidant Response, and Intestinal Integrity. International Journal of Molecular Sciences. 2026;27(15):6936. doi:10.3390/ijms27156936

BibTeX
@article{Nazir2026,
  author = {Nazir, Usman and Yang, Zhi and Zafar, Muhammad Hammad and Wan, Xiaoli and Yang, Haiming},
  title = {Alanyl-Glutamine Dipeptide Mitigates E. coli-Induced Pathogenesis in Hy-Line Brown Hens: Mechanistic Insights into Microbiome Modulation, Antioxidant Response, and Intestinal Integrity},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6936},
  doi = {10.3390/ijms27156936}
}
Kostenlos starten →